ABVC BioPharma Inc

ABVC BioPharma Inc

ABVC

Get informed when a big investor buys or sells

+ Follow
Market Cap$26M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
ABVC BioPharma IncABVC BioPharma Inc-3.4-9%-0.2
$-0.12

Current Fair Value

112.9% downside

Overvalued by 112.9% based on the discounted cash flow analysis.

Share Statistics

Market cap$26.00 Million
Enterprise Value$27.74 Million
Dividend Yield$- (-)
Earnings per Share$-0.39
Beta0.51
Outstanding Shares26,058,884

Return

Return on Equity9.22%ROE
Return on Assets4.89%
Return on Invested Capital-37.38%

Valuation & Multiples

P/E Ratio-3.39P/E Ratio
PEG4.96PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue17.43
Enterprise Value to EBIT-5.42
Enterprise Value to Net Income29
Total Debt to Enterprise0.06
Debt to Equity0.17Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 18, 2026
EPS Estimate
$-0.40
Average shareholder expectation
Revenue Estimate
$113,257
Average shareholder expectation

Next Earnings Call

Expected Date
November 16, 2026
EPS Estimate
$-0.40
Average shareholder expectation
Revenue Estimate
$113,257
Average shareholder expectation

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

ESG Score

No data

About ABVC BioPharma Inc

34 employees